| Year |
Citation |
Score |
| 2023 |
Mazur CM, Edwards WB, Haider IT, Fang Y, Morse LR, Schnitzer TJ, Simonian N, Troy KL. Bone mineral loss at the distal femur and proximal tibia following spinal cord injury in men and women. Journal of Clinical Densitometry : the Official Journal of the International Society For Clinical Densitometry. 26: 101380. PMID 37201436 DOI: 10.1016/j.jocd.2023.101380 |
0.573 |
|
| 2021 |
Troy KL, Mancuso ME, Johnson JE, Butler TA, Ngo BH, Schnitzer TJ. Dominant and nondominant distal radius microstructure: Predictors of asymmetry and effects of a unilateral mechanical loading intervention. Bone Reports. 14: 101012. PMID 33786342 DOI: 10.1016/j.bonr.2021.101012 |
0.573 |
|
| 2020 |
Barroso J, Vigotsky AD, Branco P, Reis AM, Schnitzer TJ, Galhardo V, Apkarian AV. Brain grey matter abnormalities in osteoarthritis pain: a cross-sectional evaluation. Pain. PMID 32379222 DOI: 10.1097/J.Pain.0000000000001904 |
0.336 |
|
| 2020 |
Schnitzer TJ, Khan A, Bessette L, Davignon I, Brown MT, Pixton G, Prucka WR, Tive L, Viktrup L, West CR. Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study. Seminars in Arthritis and Rheumatism. PMID 32252976 DOI: 10.1016/J.Semarthrit.2020.03.004 |
0.392 |
|
| 2020 |
Troy KL, Mancuso ME, Johnson JE, Wu Z, Schnitzer TJ, Butler TA. Bone adaptation in adult women is related to loading dose: A 12-month randomized controlled trial. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 32154945 DOI: 10.1002/Jbmr.3999 |
0.603 |
|
| 2020 |
Barroso J, Wakaizumi K, Reckziegel D, Pinto-Ramos J, Schnitzer T, Galhardo V, Apkarian AV. Prognostics for pain in osteoarthritis: Do clinical measures predict pain after total joint replacement? Plos One. 15: e0222370. PMID 31914126 DOI: 10.1371/Journal.Pone.0222370 |
0.363 |
|
| 2020 |
Berenbaum F, Kivitz A, Schnitzer T, Brown M, Donevan S, Hickman A, Viktrup L, West C, Yamabe T. Fri0392 Adverse Events In Patients With Osteoarthritis Treated With Subcutaneous Tanezumab: A Pooled Analysis Of The Overall Population And Selected Subgroups From 3 Randomised Placebo-Controlled Trials Annals of the Rheumatic Diseases. 79: 789-790. DOI: 10.1136/Annrheumdis-2020-Eular.3701 |
0.363 |
|
| 2020 |
Berenbaum F, Schnitzer T, Kivitz A, Viktrup L, Hickman A, Pixton G, Brown M, Davignon I, West C. Fri0378 General Safety And Tolerability Of Subcutaneous Tanezumab For The Treatment Of Osteoarthritis: A Pooled Analysis Of Randomized, Placebo-Controlled Trials Annals of the Rheumatic Diseases. 79: 786-786. DOI: 10.1136/Annrheumdis-2020-Eular.268 |
0.326 |
|
| 2020 |
Walsh D, Schnitzer TJ, Berenbaum F, Howland S, Wilhelm S, Junor R. O06 Improvements in pain, function and health status with subcutaneous tanezumab compared with placebo in patients with OA: pooled analysis of two randomized controlled trials Rheumatology. 59. DOI: 10.1093/Rheumatology/Keaa110.005 |
0.383 |
|
| 2019 |
Vachon-Presseau E, Berger SE, Abdullah TB, Griffith JW, Schnitzer TJ, Apkarian AV. Identification of traits and functional connectivity-based neurotraits of chronic pain. Plos Biology. 17: e3000349. PMID 31430270 DOI: 10.1371/Journal.Pbio.3000349 |
0.323 |
|
| 2019 |
Schnitzer TJ, Easton R, Pang S, Levinson DJ, Pixton G, Viktrup L, Davignon I, Brown MT, West CR, Verburg KM. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial. Jama. 322: 37-48. PMID 31265100 DOI: 10.1001/Jama.2019.8044 |
0.398 |
|
| 2019 |
Dakin P, DiMartino SJ, Gao H, Maloney J, Kivitz AJ, Schnitzer TJ, Stahl N, Yancopoulos GD, Geba GP. The Efficacy, Tolerability and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-blind, Placebo-controlled, Randomized Clinical Trial. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31207169 DOI: 10.1002/Art.41012 |
0.379 |
|
| 2019 |
Haider IT, Simonian N, Saini AS, Leung FM, Edwards WB, Schnitzer TJ. Open-label clinical trial of alendronate after teriparatide therapy in people with spinal cord injury and low bone mineral density. Spinal Cord. PMID 31164732 DOI: 10.1038/S41393-019-0303-3 |
0.336 |
|
| 2019 |
Reckziegel D, Vachon-Presseau E, Petre B, Schnitzer TJ, Baliki MN, Apkarian AV. Deconstructing biomarkers for chronic pain: context- and hypothesis-dependent biomarker types in relation to chronic pain. Pain. 160: S37-S48. PMID 31008848 DOI: 10.1097/J.Pain.0000000000001529 |
0.313 |
|
| 2019 |
Tive L, Bello AE, Radin D, Schnitzer TJ, Nguyen H, Brown MT, West CR. Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip. Journal of Pain Research. 12: 975-995. PMID 30936738 DOI: 10.2147/Jpr.S191297 |
0.374 |
|
| 2019 |
Barroso J, Wakaizumi K, Reckziegel D, Ramos J, Schnitzer T, Galhardo V, Apkarian A. Characterizing pain and relief after joint replacement in hip and knee osteoarthritis Osteoarthritis and Cartilage. 27: S416-S417. DOI: 10.1016/J.Joca.2019.02.429 |
0.357 |
|
| 2019 |
Bessette L, Schnitzer T, Khan A, Pixton G, Viktrup L, Davignon I, Tive L, Brown M, West C. Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip Osteoarthritis and Cartilage. 27: S85-S86. DOI: 10.1016/J.Joca.2019.02.122 |
0.349 |
|
| 2018 |
Haider IT, Lobos SM, Simonian N, Schnitzer TJ, Edwards WB. Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 30334093 DOI: 10.1007/S00198-018-4733-0 |
0.335 |
|
| 2018 |
Smith CL, Jin Y, Raddad E, McNearney TA, Ni X, Monteith D, Brown R, Deeg MA, Schnitzer T. Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee osteoarthritis. Pharmaceutical Statistics. PMID 30321909 DOI: 10.1002/Pst.1906 |
0.366 |
|
| 2018 |
Jin Y, Smith C, Monteith D, Brown R, Camporeale A, McNearney TA, Deeg MA, Raddad E, Xiao N, Peña A, Kivitz AJ, Schnitzer TJ. CGRP Blockade by Galcanezumab Was Not Associated with Reductions in Signs and Symptoms of Knee Osteoarthritis in a Randomized Clinical Trial. Osteoarthritis and Cartilage. PMID 30240937 DOI: 10.1016/J.Joca.2018.08.019 |
0.382 |
|
| 2018 |
Vachon-Presseau E, Berger SE, Abdullah TB, Huang L, Cecchi GA, Griffith JW, Schnitzer TJ, Apkarian AV. Brain and psychological determinants of placebo pill response in chronic pain patients. Nature Communications. 9: 3397. PMID 30209286 DOI: 10.1038/S41467-018-05859-1 |
0.363 |
|
| 2018 |
Edwards WB, Simonian N, Haider IT, Anschel AS, Chen D, Gordon KE, Gregory EK, Kim KH, Parachuri R, Troy KL, Schnitzer TJ. Effects of Teriparatide and Vibration on Bone Mass and Bone Strength in People with Bone Loss and Spinal Cord Injury: A Randomized, Controlled Trial. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 29905973 DOI: 10.1002/Jbmr.3525 |
0.639 |
|
| 2018 |
McAlindon TE, Schmidt U, Bugarin D, Abrams S, Geib T, DeGryse RE, Kim K, Schnitzer TJ. Efficacy and Safety of Single-Dose OnabotulinumtoxinA in the Treatment of Symptoms of Osteoarthritis of the Knee: Results of a Placebo-Controlled, Double-Blind Study. Osteoarthritis and Cartilage. PMID 29753118 DOI: 10.1016/J.Joca.2018.05.001 |
0.37 |
|
| 2018 |
Tétreault P, Baliki MN, Baria AT, Bauer WR, Schnitzer TJ, Apkarian AV. Inferring distinct mechanisms in the absence of subjective differences: Placebo and centrally acting analgesic underlie unique brain adaptations. Human Brain Mapping. PMID 29417694 DOI: 10.1002/Hbm.23999 |
0.363 |
|
| 2018 |
Fleischmann R, Bliddal H, Blanco F, Schnitzer T, Peterfy C, Chen S, Wang L, Conaghan P, Berenbaum F, Pelletier J-, Martel-Pelletier J, Vaeterlein O, Liu W, Levy G, Zhang L, et al. SAT0575 Safety and efficacy of lutikizumab (ABT-981), an anti–interleukin-1 alpha/beta dual variable domain (DVD) immunoglobulin, in subjects with knee osteoarthritis: results from the randomised, double-blind, placebo-controlled, parallel-group phase 2 trial Annals of the Rheumatic Diseases. 77: 1141-1142. DOI: 10.1136/Annrheumdis-2018-Eular.2727 |
0.391 |
|
| 2018 |
Schnitzer T, Bello A, West C, Pixton G, Tive L. Response to Tanezumab, as assessed by outcome measures in rheumatology-osteoarthritis research society international criteria, in patients with osteoarthritis of the knee or hip Osteoarthritis and Cartilage. 26: S299. DOI: 10.1016/J.Joca.2018.02.601 |
0.3 |
|
| 2017 |
Berger SE, Vachon-Presseau E, Abdullah TB, Baria AT, Schnitzer TJ, Apkarian AV. Hippocampal morphology mediates biased memories of chronic pain. Neuroimage. PMID 29080714 DOI: 10.1016/J.Neuroimage.2017.10.030 |
0.312 |
|
| 2017 |
Jayabalan P, Schnitzer TJ. Tanezumab in the treatment of chronic musculoskeletal conditions. Expert Opinion On Biological Therapy. 17: 245-254. PMID 27936977 DOI: 10.1080/14712598.2017.1271873 |
0.362 |
|
| 2017 |
Mcnearney T, Smith C, Brown R, Camporeale A, Deeg M, Montieth D, Collins E, Schnitzer T, Kivitz A, Talbot J, Jin Y. SAT0548 Plasma CGRP concentrations were not associated with patient OA symptoms or response to galcanezumab, a monoclonal antibody against CGRP Annals of the Rheumatic Diseases. 76: 983-984. DOI: 10.1136/Annrheumdis-2017-Eular.2155 |
0.38 |
|
| 2017 |
Maloney J, Kivitz A, Schnitzer T, Dakin P, Di Martino S, Gao H, Stehman-Breen C, Geba G. Fasinumab in the treatment of hip and knee osteoarthritic pain: efficacy and safety in a 36-week randomized, double-blind placebo-controlled clinical trial Osteoarthritis and Cartilage. 25: S56-S57. DOI: 10.1016/J.Joca.2017.02.102 |
0.394 |
|
| 2016 |
Schnitzer TJ, Torbey S, Herrmann K, Kaushal G, Yeasted R, Vania Apkarian A. A randomized placebo-controlled pilot study of the efficacy and safety of D-cycloserine in people with chronic back pain. Molecular Pain. 12. PMID 27852965 DOI: 10.1177/1744806916678627 |
0.359 |
|
| 2016 |
Tétreault P, Mansour A, Vachon-Presseau E, Schnitzer TJ, Apkarian AV, Baliki MN. Brain Connectivity Predicts Placebo Response across Chronic Pain Clinical Trials. Plos Biology. 14: e1002570. PMID 27788130 DOI: 10.1371/Journal.Pbio.1002570 |
0.353 |
|
| 2016 |
Vachon-Presseau E, Tétreault P, Petre B, Huang L, Berger SE, Torbey S, Baria AT, Mansour AR, Hashmi JA, Griffith JW, Comasco E, Schnitzer TJ, Baliki MN, Apkarian AV. Corticolimbic anatomical characteristics predetermine risk for chronic pain. Brain : a Journal of Neurology. PMID 27190016 DOI: 10.1093/Brain/Aww100 |
0.316 |
|
| 2016 |
Vachon-Presseau E, Centeno MV, Ren W, Berger SE, Tétreault P, Ghantous M, Baria A, Farmer M, Baliki MN, Schnitzer TJ, Apkarian AV. The Emotional Brain as a Predictor and Amplifier of Chronic Pain. Journal of Dental Research. PMID 26965423 DOI: 10.1177/0022034516638027 |
0.33 |
|
| 2016 |
Schnitzer TJ, Kim K, Marks J, Yeasted R, Simonian N, Chen D. Zoledronic acid treatment after acute spinal cord injury: Results of a randomized, placebo-controlled pilot trial. Pm & R : the Journal of Injury, Function, and Rehabilitation. PMID 26828618 DOI: 10.1016/J.Pmrj.2016.01.012 |
0.321 |
|
| 2015 |
Edwards WB, Schnitzer TJ. Bone Imaging and Fracture Risk after Spinal Cord Injury. Current Osteoporosis Reports. 13: 310-7. PMID 26277792 DOI: 10.1007/S11914-015-0288-6 |
0.348 |
|
| 2015 |
McAlindon TE, Driban JB, Henrotin Y, Hunter DJ, Jiang GL, Skou ST, Wang S, Schnitzer T. OARSI Clinical Trials Recommendations: Design, conduct, and reporting of clinical trials for knee osteoarthritis. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 23: 747-60. PMID 25952346 DOI: 10.1016/J.Joca.2015.03.005 |
0.327 |
|
| 2015 |
Edwards WB, Simonian N, Troy KL, Schnitzer TJ. Reduction in Torsional Stiffness and Strength at the Proximal Tibia as a Function of Time Since Spinal Cord Injury. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 30: 1422-30. PMID 25656743 DOI: 10.1002/Jbmr.2474 |
0.624 |
|
| 2015 |
Schnitzer TJ, Marks JA. A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 23: S8-17. PMID 25527221 DOI: 10.1016/J.Joca.2014.10.003 |
0.371 |
|
| 2015 |
Schnitzer TJ, Ekman EF, Spierings EL, Greenberg HS, Smith MD, Brown MT, West CR, Verburg KM. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain. Annals of the Rheumatic Diseases. 74: 1202-11. PMID 24625625 DOI: 10.1136/Annrheumdis-2013-204905 |
0.366 |
|
| 2015 |
Tetreault P, Baliki M, Vachon-Presseau E, Yeasted R, Schnitzer T, Apkarian A. Cortical singularity of knee osteoarthritis patients and their response to duloxetine or placebo treatment Osteoarthritis and Cartilage. 23: A354. DOI: 10.1016/J.Joca.2015.02.653 |
0.324 |
|
| 2014 |
McPherson JG, Edwards WB, Prasad A, Troy KL, Griffith JW, Schnitzer TJ. Dual energy X-ray absorptiometry of the knee in spinal cord injury: methodology and correlation with quantitative computed tomography. Spinal Cord. 52: 821-5. PMID 25023861 DOI: 10.1038/Sc.2014.122 |
0.575 |
|
| 2014 |
Edwards WB, Schnitzer TJ, Troy KL. Reduction in proximal femoral strength in patients with acute spinal cord injury. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 29: 2074-9. PMID 24677293 DOI: 10.1002/Jbmr.2227 |
0.625 |
|
| 2014 |
Edwards WB, Schnitzer TJ, Troy KL. The mechanical consequence of actual bone loss and simulated bone recovery in acute spinal cord injury. Bone. 60: 141-7. PMID 24361670 DOI: 10.1016/J.Bone.2013.12.012 |
0.625 |
|
| 2014 |
Mutso AA, Petre B, Huang L, Baliki MN, Torbey S, Herrmann KM, Schnitzer TJ, Apkarian AV. Reorganization of hippocampal functional connectivity with transition to chronic back pain. Journal of Neurophysiology. 111: 1065-76. PMID 24335219 DOI: 10.1152/Jn.00611.2013 |
0.337 |
|
| 2014 |
Edwards WB, Schnitzer TJ, Troy KL. Bone mineral and stiffness loss at the distal femur and proximal tibia in acute spinal cord injury. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 25: 1005-15. PMID 24190426 DOI: 10.1007/S00198-013-2557-5 |
0.619 |
|
| 2014 |
Housman L, Arden N, Schnitzer TJ, Birbara C, Conrozier T, Skrepnik N, Wei N, Bockow B, Waddell D, Tahir H, Hammond A, Goupille P, Sanson BJ, Elkins C, Bailleul F. Intra-articular hylastan versus steroid for knee osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the Esska. 22: 1684-92. PMID 23417236 DOI: 10.1007/S00167-013-2438-7 |
0.355 |
|
| 2014 |
Yeasted R, McPherson J, Schnitzer T. Characterization of osteoarthritis pain variability Osteoarthritis and Cartilage. 22: S390-S391. DOI: 10.1016/J.Joca.2014.02.728 |
0.317 |
|
| 2013 |
Malfait AM, Schnitzer TJ. Towards a mechanism-based approach to pain management in osteoarthritis. Nature Reviews. Rheumatology. 9: 654-64. PMID 24045707 DOI: 10.1038/Nrrheum.2013.138 |
0.366 |
|
| 2013 |
Mansour AR, Baliki MN, Huang L, Torbey S, Herrmann KM, Schnitzer TJ, Apkarian AV. Brain white matter structural properties predict transition to chronic pain. Pain. 154: 2160-8. PMID 24040975 DOI: 10.1016/J.Pain.2013.06.044 |
0.334 |
|
| 2013 |
Hashmi JA, Baliki MN, Huang L, Baria AT, Torbey S, Hermann KM, Schnitzer TJ, Apkarian AV. Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits. Brain : a Journal of Neurology. 136: 2751-68. PMID 23983029 DOI: 10.1093/Brain/Awt211 |
0.331 |
|
| 2013 |
Edwards WB, Schnitzer TJ, Troy KL. Torsional stiffness and strength of the proximal tibia are better predicted by finite element models than DXA or QCT. Journal of Biomechanics. 46: 1655-62. PMID 23680350 DOI: 10.1016/J.Jbiomech.2013.04.016 |
0.599 |
|
| 2013 |
Kraus VB, Feng S, Wang S, White S, Ainslie M, Graverand MP, Brett A, Eckstein F, Hunter DJ, Lane NE, Taljanovic MS, Schnitzer T, Charles HC. Subchondral bone trabecular integrity predicts and changes concurrently with radiographic and magnetic resonance imaging-determined knee osteoarthritis progression. Arthritis and Rheumatism. 65: 1812-21. PMID 23576116 DOI: 10.1002/Art.37970 |
0.34 |
|
| 2013 |
Gordon KE, Wald MJ, Schnitzer TJ. Effect of parathyroid hormone combined with gait training on bone density and bone architecture in people with chronic spinal cord injury. Pm & R : the Journal of Injury, Function, and Rehabilitation. 5: 663-71. PMID 23558091 DOI: 10.1016/J.Pmrj.2013.03.032 |
0.37 |
|
| 2013 |
Edwards WB, Schnitzer TJ, Troy KL. Bone mineral loss at the proximal femur in acute spinal cord injury. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 24: 2461-9. PMID 23468075 DOI: 10.1007/S00198-013-2323-8 |
0.611 |
|
| 2013 |
Schnitzer T, Yeasted R, Huang L, Baliki M, Apkarian A. OA pain shows anti-persistent time series Osteoarthritis and Cartilage. 21: S261-S262. DOI: 10.1016/J.Joca.2013.02.545 |
0.329 |
|
| 2012 |
Hashmi JA, Baria AT, Baliki MN, Huang L, Schnitzer TJ, Apkarian AV. Brain networks predicting placebo analgesia in a clinical trial for chronic back pain. Pain. 153: 2393-402. PMID 22985900 DOI: 10.1016/J.Pain.2012.08.008 |
0.345 |
|
| 2012 |
Baliki MN, Petre B, Torbey S, Herrmann KM, Huang L, Schnitzer TJ, Fields HL, Apkarian AV. Corticostriatal functional connectivity predicts transition to chronic back pain. Nature Neuroscience. 15: 1117-9. PMID 22751038 DOI: 10.1038/Nn.3153 |
0.331 |
|
| 2012 |
Hashmi JA, Baliki MN, Huang L, Parks EL, Chanda ML, Schnitzer T, Apkarian AV. Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study. Molecular Pain. 8: 29. PMID 22531485 DOI: 10.1186/1744-8069-8-29 |
0.374 |
|
| 2012 |
Schnitzer TJ, Pelletier JP, Haselwood DM, Ellison WT, Ervin JE, Gordon RD, Lisse JR, Archambault WT, Sampson AR, Fezatte HB, Phillips SB, Bernstein JE. Civamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week randomized controlled clinical trial with a longterm extension. The Journal of Rheumatology. 39: 610-20. PMID 22089461 DOI: 10.3899/Jrheum.110192 |
0.367 |
|
| 2012 |
Jensen MP, Schnitzer TJ, Wang H, Smugar SS, Peloso PM, Gammaitoni A. Sensitivity of single-domain versus multiple-domain outcome measures to identify responders in chronic low-back pain: pooled analysis of 2 placebo-controlled trials of etoricoxib. The Clinical Journal of Pain. 28: 1-7. PMID 21705875 DOI: 10.1097/Ajp.0B013E3182236209 |
0.346 |
|
| 2012 |
Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Efficacy of tramadol in treatment of pain in fibromyalgia. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 6: 250-7. PMID 19078481 DOI: 10.1097/00124743-200010000-00004 |
0.388 |
|
| 2011 |
Baliki MN, Schnitzer TJ, Bauer WR, Apkarian AV. Brain morphological signatures for chronic pain. Plos One. 6: e26010. PMID 22022493 DOI: 10.1371/Journal.Pone.0026010 |
0.323 |
|
| 2011 |
Schnitzer TJ, Dattani ID, Seriolo B, Schneider H, Moore A, Tseng L, Sallstig P, Rebuli R, Maxwell T. A 13-week, multicenter, randomized, double-blind study of lumiracoxib in hip osteoarthritis. Clinical Rheumatology. 30: 1433-46. PMID 21607551 DOI: 10.1007/S10067-011-1776-4 |
0.378 |
|
| 2011 |
White WB, Schnitzer TJ, Bakris GL, Frayssinet H, Duquesroix B, Weber M. Effects of naproxcinod on blood pressure in patients with osteoarthritis. The American Journal of Cardiology. 107: 1338-45. PMID 21371681 DOI: 10.1016/J.Amjcard.2010.12.046 |
0.339 |
|
| 2011 |
Parks EL, Geha PY, Baliki MN, Katz J, Schnitzer TJ, Apkarian AV. Brain activity for chronic knee osteoarthritis: dissociating evoked pain from spontaneous pain. European Journal of Pain (London, England). 15: 843.e1-14. PMID 21315627 DOI: 10.1016/J.Ejpain.2010.12.007 |
0.364 |
|
| 2011 |
Schnitzer TJ, Lane NE, Birbara C, Smith MD, Simpson SL, Brown MT. Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 19: 639-46. PMID 21251985 DOI: 10.1016/J.Joca.2011.01.009 |
0.414 |
|
| 2011 |
Schnitzer TJ, Hochberg MC, Marrero CE, Duquesroix B, Frayssinet H, Beekman M. Efficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter study. Seminars in Arthritis and Rheumatism. 40: 285-97. PMID 20828790 DOI: 10.1016/J.Semarthrit.2010.06.002 |
0.347 |
|
| 2010 |
Lane NE, Schnitzer TJ, Birbara CA, Mokhtarani M, Shelton DL, Smith MD, Brown MT. Tanezumab for the treatment of pain from osteoarthritis of the knee. The New England Journal of Medicine. 363: 1521-31. PMID 20942668 DOI: 10.1056/Nejmoa0901510 |
0.423 |
|
| 2010 |
Schnitzer TJ, Kivitz A, Frayssinet H, Duquesroix B. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study. Osteoarthritis and Cartilage. 18: 629-39. PMID 20202489 DOI: 10.1016/J.Joca.2009.12.013 |
0.348 |
|
| 2010 |
Hochberg M, Schnitzer T, Marrero C, Berembaum F, Duquesroix B, Frayssinet H. 330 EFFECTS OF NAPROXCINOD AND NAPROXEN ON CHANGE IN JOINT SPACE WIDTH IN THE TIBIO-FEMORAL JOINT: RESULTS OF A 52-WEEK, RANDOMIZED CONTROLLED TRIAL Osteoarthritis and Cartilage. 18: S146. DOI: 10.1016/S1063-4584(10)60357-3 |
0.32 |
|
| 2010 |
Jensen M, Schnitzer T, Katz N, Wang H, Peloso P, Smugar S, Gammaitoni A. Correlation of outcome measures and responder identification sensitivity in chronic low back pain: pooled analysis of 2 trials of etoricoxib The Journal of Pain. 11: S2. DOI: 10.1016/J.Jpain.2010.01.015 |
0.324 |
|
| 2009 |
White WB, Schnitzer TJ, Fleming R, Duquesroix B, Beekman M. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis. The American Journal of Cardiology. 104: 840-5. PMID 19733721 DOI: 10.1016/J.Amjcard.2009.05.014 |
0.306 |
|
| 2009 |
Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial. The Journal of Rheumatology. 36: 1705-14. PMID 19487264 DOI: 10.3899/Jrheum.081207 |
0.402 |
|
| 2009 |
Karlsson J, Pivodic A, Aguirre D, Schnitzer TJ. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee. The Journal of Rheumatology. 36: 1290-7. PMID 19411388 DOI: 10.3899/Jrheum.081011 |
0.313 |
|
| 2009 |
Hellio Le Graverand MP, Buck RJ, Wyman BT, Vignon E, Mazzuca SA, Brandt KD, Piperno M, Charles HC, Hudelmaier M, Hunter DJ, Jackson C, Kraus VB, Link TM, Majumdar S, Prasad PV, ... Schnitzer TJ, et al. Subregional femorotibial cartilage morphology in women - comparison between healthy controls and participants with different grades of radiographic knee osteoarthritis Osteoarthritis and Cartilage. 17: 1177-1185. PMID 19341831 DOI: 10.1016/J.Joca.2009.03.008 |
0.308 |
|
| 2009 |
Schnitzer TJ, Tesser JRP, Cooper KM, Altman RD. A 4-week randomized study of acetaminophen extended-release vs rofecoxib in knee osteoarthritis Osteoarthritis and Cartilage. 17: 1-7. PMID 18640856 DOI: 10.1016/J.Joca.2008.05.018 |
0.371 |
|
| 2009 |
Gammaitoni A, Katz N, Schnitzer T, Mehta A, Wang H, Peloso P. 264 BASELINE PREDICTORS OF RESPONSE USING A POOLED ANALYSIS OF TWO RANDOMIZED CONTROLLED STUDIES IN CHRONIC LOW BACK PAIN (LBP) PATIENTS European Journal of Pain. 13: S83. DOI: 10.1016/S1090-3801(09)60267-6 |
0.35 |
|
| 2009 |
Schnitzer T, Moore R, Katz N, Gammaitoni A, Mehta A, Wang H, Peloso P. 263 LONGITUDINAL NUMBERS-NEEDED-TO-TREAT (NNT) ANALYSES OF ANALGESIC TREATMENTS FOR CHRONIC LOW BACK PAIN TO ACHIEVE VARYING RESPONSE LEVELS AND STABILITY European Journal of Pain. 13: S83. DOI: 10.1016/S1090-3801(09)60266-4 |
0.326 |
|
| 2009 |
Lane N, Schnitzer T, Birbara C, Smith M, Simpson S, Brown M. 322 SAFETY OF TANEZUMAB IN TREATING MODERATE TO SEVERE PAIN DUE TO OSTEOARTHRITIS OF THE KNEE: AN OPEN-LABEL EXTENSION STUDY Osteoarthritis and Cartilage. 17: S172. DOI: 10.1016/S1063-4584(09)60344-7 |
0.369 |
|
| 2008 |
Baliki MN, Geha PY, Jabakhanji R, Harden N, Schnitzer TJ, Apkarian AV. A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis. Molecular Pain. 4: 47. PMID 18950528 DOI: 10.1186/1744-8069-4-47 |
0.357 |
|
| 2007 |
Goemaere S, Liberman UA, Adachi JD, Hawkins F, Lane N, Saag KG, Schnitzer T, Kaufman JM, Malice MP, Carofano W, Daifotis A. Incidence of nonvertebral fractures in relation to time on treatment and bone density in glucocorticoid-treated patients: a retrospective approach. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 9: 170-5. PMID 17041453 DOI: 10.1097/01.Rhu.0000073586.28977.31 |
0.329 |
|
| 2007 |
Sheldon E, Beaulieu A, Pavelka K, Alten R, Krammer G, Stricker K, Rebuli R, Yu S, Schnitzer T. 267 COMPARISON OF EFFICACY OF LUMIRACOXIB 100 MG OD WITH CELECOXIB 200 MG OD IN THE OVERALL POPULATION AND AGE GROUPS <65 AND ≥65: COMBINED ANALYSIS OF TWO PIVOTAL STUDIES IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE Osteoarthritis and Cartilage. 15: C150. DOI: 10.1016/S1063-4584(07)61899-8 |
0.305 |
|
| 2007 |
Schnitzer T, Beaulieu A, Pavelka K, Alten R, Moore A, Krammer G, Stricker K, Rebuli R, Sheldon E. 260 COMPARISON OF EFFICACY OF LUMIRACOXIB WITH CELECOXIB AND PLACEBO IN KNEE OSTEOARTHRITIS PATIENTS AND DIFFERING BASELINE DISEASE SEVERITY Osteoarthritis and Cartilage. 15: C146-C147. DOI: 10.1016/S1063-4584(07)61892-5 |
0.354 |
|
| 2007 |
Schnitzer T, Dattani I, Seriolo B, Schneider H, Yu S, Tseng L, Rebuli R. 249 LUMIRACOXIB IMPROVES PAIN AND FUNCTIONAL STATUS IN PATIENTS WITH PRIMARY HIP OSTEOARTHRITIS: A 13-WEEK, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, ACTIVE COMPARATOR TRIAL Osteoarthritis and Cartilage. 15: C141. DOI: 10.1016/S1063-4584(07)61881-0 |
0.386 |
|
| 2006 |
Smugar SS, Schnitzer TJ, Weaver AL, Rubin BR, Polis AB, Tershakovec AM. Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies. Current Medical Research and Opinion. 22: 1353-67. PMID 16834834 DOI: 10.1185/030079906X104876 |
0.313 |
|
| 2006 |
Schnitzer TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clinical Rheumatology. 25: S22-9. PMID 16741783 DOI: 10.1007/S10067-006-0203-8 |
0.358 |
|
| 2006 |
Schnitzer TJ. Pain management today - optimising the benefit/risk ratio: defining the role of weak opioids and combination analgesics. Clinical Rheumatology. 25: S1. PMID 16741782 DOI: 10.1007/S10067-006-0204-7 |
0.349 |
|
| 2006 |
Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR, Oddis CV, ... ... Schnitzer TJ, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. The New England Journal of Medicine. 354: 795-808. PMID 16495392 DOI: 10.1056/Nejmoa052771 |
0.4 |
|
| 2005 |
Schnitzer TJ, Kivitz AJ, Lipetz RS, Sanders N, Hee A. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee. Arthritis and Rheumatism. 53: 827-37. PMID 16342089 DOI: 10.1002/Art.21586 |
0.325 |
|
| 2005 |
Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum DE, Wolfe F, Schnitzer TJ, Moreland LW, Manzi S, Bradley JD, Sharma L, Oddis CV, Hugenberg ST, Heck LW. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis and Rheumatism. 52: 2015-25. PMID 15986343 DOI: 10.1002/Art.21122 |
0.324 |
|
| 2005 |
Schnitzer TJ, Gitton X, Jayawardene S, Sloan VS. Lumiracoxib in the treatment of osteoarthritis, rheumatoid arthritis and acute postoperative dental pain: results of three dose-response studies. Current Medical Research and Opinion. 21: 151-61. PMID 15881487 DOI: 10.1185/030079904X20231 |
0.35 |
|
| 2004 |
Lee C, Straus WL, Balshaw R, Barlas S, Vogel S, Schnitzer TJ. A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. Arthritis and Rheumatism. 51: 746-54. PMID 15478167 DOI: 10.1002/Art.20698 |
0.324 |
|
| 2004 |
Schnitzer TJ, Beier J, Geusens P, Hasler P, Patel SK, Senftleber I, Gitton X, Moore A, Sloan VS, Poór G. Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism. 51: 549-57. PMID 15334426 DOI: 10.1002/Art.20525 |
0.411 |
|
| 2004 |
Altman RD, Akermark C, Beaulieu AD, Schnitzer T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis and Cartilage. 12: 642-9. PMID 15262244 DOI: 10.1016/J.Joca.2004.04.010 |
0.322 |
|
| 2004 |
Schnitzer TJ, Ferraro A, Hunsche E, Kong SX. A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain. Journal of Pain and Symptom Management. 28: 72-95. PMID 15223086 DOI: 10.1016/J.Jpainsymman.2003.10.015 |
0.347 |
|
| 2003 |
Gottesdiener K, Schnitzer T, Fisher C, Bockow B, Markenson J, Ko A, DeTora L, Curtis S, Geissler L, Gertz BJ. Erratum: A randomized placebo-controlled trial of arthroscopic lavage versus lavage plus intra-articular corticosteroids in the management of symptomatic osteoarthritis of the knee (Rheumatology (2003) vol. 42 (123-134)) Rheumatology. 42. DOI: 10.1093/Rheumatology/Keg416 |
0.33 |
|
| 2002 |
Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, et al. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Arthritis and Rheumatism. 46: 2020-8. PMID 12209503 DOI: 10.1002/Art.10427 |
0.302 |
|
| 2002 |
Gottesdiener K, Schnitzer T, Fisher C, Bockow B, Markenson J, Ko A, DeTora L, Curtis S, Geissler L, Gertz BJ. Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis. Rheumatology (Oxford, England). 41: 1052-61. PMID 12209041 DOI: 10.1093/Rheumatology/41.9.1052 |
0.333 |
|
| 2002 |
Schnitzer TJ, Hochberg MC. COX-2-selective inhibitors in the treatment of arthritis. Cleveland Clinic Journal of Medicine. 69: SI20-30. PMID 12086290 DOI: 10.3949/Ccjm.69.Suppl_1.Si20 |
0.334 |
|
| 2002 |
Greenspan SL, Schneider DL, McClung MR, Miller PD, Schnitzer TJ, Bonin R, Smith ME, DeLucca P, Gormley GJ, Melton ME. Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities: A randomized, double-blind, placebo-controlled trial Annals of Internal Medicine. 136: 742-746. PMID 12020142 DOI: 10.7326/0003-4819-136-10-200205210-00009 |
0.344 |
|
| 2002 |
Schnitzer TJ. Update of ACR guidelines for osteoarthritis: role of the coxibs. Journal of Pain and Symptom Management. 23: S24-30; discussion S. PMID 11992747 DOI: 10.1016/S0885-3924(02)00372-X |
0.34 |
|
| 2002 |
Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. Jama. 287: 64-71. PMID 11754710 DOI: 10.1001/Jama.287.1.64 |
0.345 |
|
| 2001 |
Schnitzer TJ. Update on alendronate for osteoporosis: once-weekly dosing. Expert Opinion On Pharmacotherapy. 2: 1461-72. PMID 11585024 DOI: 10.1517/14656566.2.9.1461 |
0.353 |
|
| 2001 |
Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, Luta G, Callahan LF, Wang X, Schwartz T, Abramson SB, Caldwell JR, Harrell RA, Kremer JM, Lautzenheiser RL, ... ... Schnitzer TJ, et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee Arthritis and Rheumatism. 44: 1587-1598. PMID 11465710 DOI: 10.1002/1529-0131(200107)44:7<1587::Aid-Art282>3.0.Co;2-X |
0.354 |
|
| 2001 |
Bell GM, Schnitzer TJ. Cox-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly. Clinics in Geriatric Medicine. 17: 489-502, vi. PMID 11459717 DOI: 10.1016/S0749-0690(05)70082-3 |
0.322 |
|
| 2001 |
Murphy MG, Weiss S, McClung M, Schnitzer T, Cerchio K, Connor J, Krupa D, Gertz BJ. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. The Journal of Clinical Endocrinology and Metabolism. 86: 1116-25. PMID 11238495 DOI: 10.1210/Jcem.86.3.7294 |
0.362 |
|
| 2001 |
Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis and Rheumatism. 44: 202-11. PMID 11212161 DOI: 10.1002/1529-0131(200101)44:1<202::Aid-Anr27>3.0.Co;2-W |
0.369 |
|
| 2001 |
Rizzoli R, Roux C, Greenspan S, Bone H, Schnitzer T, Watts N, Adami S, Uebelhart B, Foldes J, Peverly C, Santora A, Kaur A, Wu M, Orloff J. SAT0164 Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosisis Annals of the Rheumatic Diseases. 60. DOI: 10.1136/Annrheumdis-2001.651 |
0.327 |
|
| 2000 |
Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. The New England Journal of Medicine. 343: 1520-8, 2 p followin. PMID 11087881 DOI: 10.1056/Nejm200011233432103 |
0.312 |
|
| 2000 |
Hurwitz DE, Ryals AR, Block JA, Sharma L, Schnitzer TJ, Andriacchi TP. Knee pain and joint loading in subjects with osteoarthritis of the knee. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 18: 572-9. PMID 11052493 DOI: 10.1002/Jor.1100180409 |
0.383 |
|
| 2000 |
Yocum DE, Allard S, Cohen SB, Emery P, Flipo RM, Goobar J, Jayawardena S, Job-Deslandre C, Jubb RW, Krüger K, Lopes Vaz A, Manger B, Mur E, Nygaard H, Weiner SM, ... ... Schnitzer TJ, et al. Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group. Rheumatology (Oxford, England). 39: 156-64. PMID 10725065 DOI: 10.1093/Rheumatology/39.2.156 |
0.345 |
|
| 2000 |
Schnitzer T, Bone HG, Crepaldi G, Adami S, McClung M, Kiel D, Felsenberg D, Recker RR, Tonino RP, Roux C, Pinchera A, Foldes AJ, Greenspan SL, Levine MA, Emkey R, et al. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis Aging Clinical and Experimental Research. 12: 1-12. DOI: 10.1007/Bf03339822 |
0.358 |
|
| 1999 |
Mehlisch DR, Markenson J, Schnitzer TJ. The Efficacy of Nonsteroidal Anti-inflammatory Drugs for Acute Pain. Cancer Control : Journal of the Moffitt Cancer Center. 6: 5-9. PMID 12118232 DOI: 10.1177/107327489900602S01 |
0.321 |
|
| 1999 |
Schnitzer TJ, Truitt K, Fleischmann R, Dalgin P, Block J, Zeng Q, Bolognese J, Seidenberg B, Ehrich EW. The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group. Clinical Therapeutics. 21: 1688-702. PMID 10566565 DOI: 10.1016/S0149-2918(99)80048-4 |
0.348 |
|
| 1999 |
Schnitzer TJ, Kamin M, Olson WH. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study. Arthritis and Rheumatism. 42: 1370-7. PMID 10403264 DOI: 10.1002/1529-0131(199907)42:7<1370::Aid-Anr10>3.0.Co;2-T |
0.38 |
|
| 1998 |
Schnitzer TJ. Non-NSAID pharmacologic treatment options for the management of chronic pain. The American Journal of Medicine. 105: 45S-52S. PMID 9715834 DOI: 10.1016/S0002-9343(98)00073-4 |
0.35 |
|
| 1998 |
Sharma L, Hurwitz DE, Thonar EJ, Sum JA, Lenz ME, Dunlop DD, Schnitzer TJ, Kirwan-Mellis G, Andriacchi TP. Knee adduction moment, serum hyaluronan level, and disease severity in medial tibiofemoral osteoarthritis. Arthritis and Rheumatism. 41: 1233-40. PMID 9663481 DOI: 10.1002/1529-0131(199807)41:7<1233::Aid-Art14>3.0.Co;2-L |
0.328 |
|
| 1998 |
Schnitzer TJ, Donahue JR, Toomey EP, Holtby RM, Scuderi GR, Adams PL, Poland MP. Effect of nabumetone on hemostasis during arthroscopic knee surgery. Clinical Therapeutics. 20: 110-24. PMID 9522109 DOI: 10.1016/S0149-2918(98)80039-8 |
0.312 |
|
| 1997 |
Sum J, Hurwitz D, Janik R, Dressander J, Andriacchi T, Schnitzer T, Andersson G. 15 The impact of osteoarthritic knee pain on dynamic loads during gait Gait & Posture. 5: 173. DOI: 10.1016/S0966-6362(97)83412-1 |
0.321 |
|
| 1996 |
Schnitzer TJ, Ballard IM, Constantine G, McDonald P. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee. Clinical Therapeutics. 17: 602-12. PMID 8565024 DOI: 10.1016/0149-2918(95)80037-9 |
0.35 |
|
| 1995 |
Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW, Schnitzer TJ. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis and Rheumatism. 38: 1541-6. PMID 7488273 DOI: 10.1002/Art.1780381104 |
0.346 |
|
| 1995 |
Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW, Schnitzer TJ. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis and Rheumatism. 38: 1535-40. PMID 7488272 DOI: 10.1002/Art.1780381103 |
0.35 |
|
| 1995 |
Schnitzer TJ, Posner M, Lawrence ID. High Strength Capsaicin Cream for Osteoarthritis Pain Jcr: Journal of Clinical Rheumatology. 1: 268-273. DOI: 10.1097/00124743-199510000-00003 |
0.332 |
|
| 1994 |
Schnitzer T, Morton C, Coker S. Topical capsaicin therapy for osteoarthritis pain: Achieving a maintenance regimen Seminars in Arthritis and Rheumatism. 23: 34-40. DOI: 10.1016/S0049-0172(10)80024-1 |
0.383 |
|
| 1994 |
Schnitzer T. Neuropeptides, capsaicin, and musculoskeletal pain: Introduction Seminars in Arthritis and Rheumatism. 23: 1-2. DOI: 10.1016/S0049-0172(10)80019-8 |
0.322 |
|
| 1993 |
Schnitzer TJ. Osteoarthritis treatment update. Minimizing pain while limiting patient risk. Postgraduate Medicine. 93: 89-92, 95. PMID 8418462 DOI: 10.1080/00325481.1993.11701575 |
0.357 |
|
| 1993 |
Schnitzer TJ, Popovich JM, Andersson GBJ, Andriacchi TP. Effect of piroxicam on gait in patients with osteoarthritis of the knee Arthritis and Rheumatism. 36: 1207-1213. PMID 8216414 DOI: 10.1002/Art.1780360905 |
0.405 |
|
| Show low-probability matches. |